Symbol
| MAL
| contributors: mct - updated : 08-06-2017
|
HGNC name
| mal, T-cell differentiation protein
|
HGNC id
| 6817
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --low
|  
|
in esophageal cancer | tumoral
|  
|  
| --low
|  
|
in head and neck squamous cell carcinoma | tumoral
|  
|  
| --low
|  
|
most down-regulated gene in cervical cancer, by promoter methylation (by promoter methylation) | constitutional
|  
|  
| --over
|  
|
is also associated with shortened or absent cilia, and cyst development | constitutional
|  
|  
| --over
|  
|
leads to disturbed expression of genes that influence cytoskeletal organization and differentiation of Schwann cells | |
Variant & Polymorphism
SNP
|
| |
Candidate gene
Marker
| inactivation of MAL, as a candidate tumor suppressor gene, can contribute to human epithelial cell carcinoma and may be served as a biomarker in head and neck squamous cell carcinoma | Therapy target
| | |
| overexpression of MAL/VIP17 in the kidney of transgenic mice results in cysts formation in distal nephron structures |